TipRanks
Go Ultimate55% OFF

Vaxil Bio (VXL) Income Statement

Vaxil Bio Income Statement

Last quarter (Q2 2026), Vaxil Bio's total revenue was $0.00. In Q2, Vaxil Bio's net income was $-64.00K. See Vaxil Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Mar 22
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ -2.00K$ -25.00K
$ 179.00K$ 196.00K$ 254.00K$ 584.00K$ 986.00K
Depreciation and Amortization$ 0.00$ 148.00K$ 2.00K$ 2.00K$ 25.00K
$ -179.00K$ -30.00K$ -252.00K$ -582.00K$ -961.00K
$ -179.00K$ -196.00K$ -254.00K$ -584.00K$ -986.00K
$ 700.00K$ 18.00K$ 0.00$ 0.00$ 0.00
$ 521.00K$ -178.00K$ -254.00K$ -584.00K$ -986.00K
$ 522.00K$ -178.00K$ -254.00$ -584.00K$ -986.00K
Per Share Metrics
Basic EPS$ 0.18$ -0.00$ -0.10$ 0.00$ -0.01
Diluted EPS$ 0.18$ -0.00$ -0.10$ 0.00$ -0.01
Weighted Average Shares Outstanding2.84M136.98M136.98M136.98M136.10M
Weighted Average Shares Outstanding (Diluted)2.84M136.98M136.98M136.98M136.10M

Currency in CAD

Vaxil Bio Earnings and Revenue History

-2M-1M01M0 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin